Denali Therapeutics Inc.
USPTO PatentsView assignee record - 51 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Denali ranks #6,517 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 12 technology areas.
- #6,517
- of 49,997 US assignees by volume
- Top 7%
- by Innovation Score (54.7/100)
- 25.2
- avg claims per patent
- +322%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6517 · US Corporation #6,517 · 51 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 51 grants
- UPPER-Q #6,517/49,997
- PHOTO-FINISH Cotapaxi Custom…
- CPC-FOCUS A61P · 12 areas
- INNOV-PAR 54.7/100
- CLAIMS-DENSE 25.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +322% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cotapaxi Custom Design and Manufacturing LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Denali’s 54.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Denali
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AAC Optics Solutions… · near
AAC Optics Solutions… · near
55 score
- Aisin Seiki · near
Aisin Seiki · near
55 score
- Denali Therapeutics · this assignee
Denali Therapeutics · this assignee
55 score
- Lite-on Opto… · near
Lite-on Opto… · near
55 score
- Midtronics · near
Midtronics · near
55 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Denali's Innovation Score is 54.7/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Denali?
Each dot is one of Denali’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Denali’s own 25.2 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Denali's grants concentrate
Denali Therapeutics Inc. is a focused PatentsView assignee: 12 CPC subclasses with 70.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (12 grants) versus a trough of 2 in 2019. By volume, Denali sits between Cotapaxi Custom Design and Manufacturing LLC and Eden Collection B.V..
Denali's three-year grant acceleration
Denali Therapeutics Inc. shows 27 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Denali's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cotapaxi Custom D…
Cotapaxi Custom Design and Manufacturing LLC
51 patents
- D&M Holdings
D&M Holdings Inc.
51 patents
- D R Systems
D.R. Systems, Inc.
51 patents
- Dana
Dana Limited
51 patents
- Digital Ally
Digital Ally, Inc.
51 patents
- Elite Material
Elite Material Co., Ltd.
51 patents
- Ezconn
Ezconn Corporation
51 patents
- Eden Collection B…
Eden Collection B.V.
51 patents
- Denali Therapeuti… ◀
Denali Therapeutics Inc.
51 patents
What this shows Denali holds 51 patents at rank #6,519, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Denali
By rank, the assignees closest to #6,519 in granted patent volume.
- Cotapaxi Custom Design and Manufacturing LLC #6,515 · 51 patents
- D&M Holdings Inc. #6,516 · 51 patents
- D.R. Systems, Inc. #6,517 · 51 patents
- Dana Limited #6,518 · 51 patents
- Digital Ally, Inc. #6,520 · 51 patents
- Elite Material Co., Ltd. #6,521 · 51 patents
- Ezconn Corporation #6,522 · 51 patents
- Eden Collection B.V. #6,523 · 51 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Denali's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Denali, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Denali ranks #522 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (55 here).
Similar claim depth
Nearest assignees by average claims per patent (25.2 here).
Denali's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
55 Top 7% higher than 93% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 5.9% |
| 2018 | 4 | 7.8% |
| 2019 | 2 | 3.9% |
| 2020 | 5 | 9.8% |
| 2021 | 6 | 11.8% |
| 2022 | 5 | 9.8% |
| 2023 | 12 | 23.5% |
| 2024 | 10 | 19.6% |
| 2025partial year | 4 | 7.8% |
Which technologies does Denali Therapeutics Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Denali Therapeutics Inc.'s patent record in context - here's where to go next.
- Denali Therapeutics Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70.6% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #6,517 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Denali Therapeutics Inc. against Cotapaxi Custom Design and Manufacturing LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 54.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.